Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder
Public ClinicalTrials.gov record NCT03544112. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
NIDA CTN-0079: Emergency Department Connection to Care With Buprenorphine for Opioid Use Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to learn what resources are needed to improve outcomes for patients with opioid use disorder. The study will look at how patients engage in treatment and the decisions that patients and providers make regarding treatment, specifically buprenorphine treatment, for opioid use disorder. The aims of this study are: 1. To evaluate using mixed methods the feasibility and acceptability of OUD screening, ED-initiated BUP, and referral. 2. Over the course of the study and as XR-BUP is added to hospital formularies, to estimate the percentage and confidence intervals of patients assessed, treated, and engaged in treatment at Day 30. This will be a three-site study employing a multi-faceted approach to facilitate clinical protocol implementation and to assess feasibility, acceptability, and impact. Investigators will develop, introduce and update site-specific ED clinical protocols and implementation plans for OUD screening, ED-initiated BUP, and referral for treatment. A participatory action research approach will be utilized along with mixed methods incorporating data derived from: * Medical record and administrative data abstraction, * Research assessments involving patients who are eligible for and willing to receive ED-initiated BUP (including both those who do, and do not, receive BUP); these assessments will document the index ED visit and the 30th day after the index ED visit, * Qualitative interviews, focus groups, and quantitative assessments involving providers and staff, patients, and other stakeholders.
Study identification
- NCT ID
- NCT03544112
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 390 participants
Conditions and interventions
Conditions
Interventions
- Employ a multifaceted approach to facilitate clinical protocol implementation Behavioral
- Initiate BUP (SL-BUP or XR-BUP) in the ED Drug
Behavioral · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 10, 2018
- Primary completion
- May 28, 2019
- Completion
- May 28, 2019
- Last update posted
- Aug 29, 2019
2018 – 2019
United States locations
- U.S. sites
- 4
- U.S. states
- 2
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Valley Regional Healthcare | Claremont | New Hampshire | 03743 | — |
| Catholic Medical Center | Manchester | New Hampshire | 03102 | — |
| Bellevue Hospital Center | New York | New York | 10016 | — |
| New York University School of Medicine | New York | New York | 10016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Opioid-use Disorder trials
Other public records listing Opioid-use Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT07795840: The ConCERN Intervention for Loved Ones of Those With Opioid Use Disorder Not yet recruiting
- NCT07787039: Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase Not yet recruiting
- NCT07780097: TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization Recruiting
- NCT07778394: Personalized Addiction Treatment eHancement Recruiting
- NCT07610746: Cerebral Physiology of NOWS Recruiting
- NCT07770555: Deep Transcranial Magnetic Stimulation for Tobacco Cessation in Adults With Opioid Use Disorder Not yet recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03544112, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 29, 2019 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03544112 live on ClinicalTrials.gov.